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Chlamydia trachomatis infections are the most prevalent sexually transmitted infections
with potentially debilitating sequelae, such as infertility. Mouse models are generally used
for vaccine development, to study the immune response and histopathology associated
with Chlamydia infection. An important question regarding murine models is the in
vivo identification of murine host genes responsible for the elimination of the murine
and human Chlamydia strains. RNA sequencing of the Chlamydia muridarum infected
BALB/c lung transcriptome revealed that several genes with direct antichlamydial
functions were induced at the tissue level, including the already described and novel
members of the murine interferon-inducible GTPase family, the CXCL chemokines
CXCL9, CXCL11, immunoresponsive gene 1, nitric oxide synthase-2 (iNOS), and
lipocalin-2. Indoleamine 2,3-dioxygenase 1-2 (IDO1-2) previously described potent
antichlamydial host enzymes were also highly expressed in the infected murine lungs.
This finding was novel, since IDO was considered as a unique human antichlamydial
defense gene. Besides a lower level of epithelial cell positivity, immunohistochemistry
showed that IDO1-2 proteins were expressed prominently in macrophages. Detection
of the tryptophan degradation product kynurenine and the impact of IDO inhibition
on Chlamydia muridarum growth proved that the IDO1-2 proteins were functionally
active. IDO1-2 activity also increased in Chlamydia muridarum infected C57BL/6 lung
tissues, indicating that this phenomenon is not mouse strain specific. Our study
shows that the murine antichlamydial response includes a variety of highly up-regulated
defense genes in vivo. Among these genes the antichlamydial effectors IDO1-2 were
identified. The potential impact of murine IDO1-2 expression on Chlamydia propagation
needs further investigation.
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INTRODUCTION
Chlamydiae are obligate intracellular bacteria that propagate
prominently in the epithelial cells of the respiratory and
urogenital tract. The socioeconomic impact of C. trachomatis
infection is significant. In developing countries, the
ocular serovars of the species cause trachoma, the chronic
infection/inflammation of the conjunctiva. Trachoma is the most
important cause of preventable, infection-related blindness and
in 2008 about 40 million people had active trachoma infection
(Mariotti et al., 2009). Urogenital serotypes of Chlamydia
trachomatis (C. trachomatis) are the most prevalent bacteria
related to sexually transmitted infections (Centers for Disease
Control Prevention, 2014), frequently leading to chronic
infections with debilitating sequelae such as ectopic pregnancy
and infertility. C. trachomatis infections can be treated effectively
with macrolides and doxycycline (Kong et al., 2014), but the
symptoms of urogenital infections are frequently mild and
therefore the infection may be left untreated (Lallemand et al.,
2016). Though the prevention of the infection with vaccination
would be important, an effective vaccine has not yet been
developed. Mouse models are the most frequently used ones
for vaccine development, but the differences between the
human and murine immune systems, including the so-called
cell-autonomous immunity makes the mouse models difficult
to compare with humans (Finethy and Coers, 2016). Cell
autonomous immunity is an intrinsic feature of the host cells,
which launches defense mechanisms that interfere with the
growth of intracellular pathogens. Typically these defense genes
are inducible, and interferon-gamma (IFNG) is a prominent
inducer cytokine. It has been described previously that the
major intracellular antichlamydial defense mechanism in human
cells is the IFNG-induced IDO expression, which leads to the
degradation of the intracellular tryptophan pool and eventually
the death of the tryptophan-auxotroph C. trachomatis (Byrne
et al., 1986). This elimination mechanism is effective in vitro for
both the human C. trachomatis and the genetically closely related
murine Chlamydia species C. muridarum (Roshick et al., 2006).
Nevertheless in vitro data showed that IDO is not inducible
by Chlamydia infection and/or IFNG in mouse epithelial cells
(Roshick et al., 2006). Instead, microarray analysis of IFNG
treated and Chlamydia infected murine epithelial cells revealed
that the IFN-inducible GTPases are the suspected host genes
that interfere with the developmental cycle of human Chlamydia
strains (Nelson et al., 2005). Murine Chlamydia strain developed
mechanism(s) to inactivate the GTPase response and render this
elimination mechanism ineffective (Nelson et al., 2005; Coers
et al., 2008). Despite this, the C. muridarum strain is rapidly
eliminated from the murine cervicovaginal tract (Nelson et al.,
2005), hence yet unknown elimination mechanisms exist in mice
that are effective against the murine Chlamydia strain in vivo.
The aim of our experiments was to find murine defense
genes that could be involved in the elimination of the murine
Chlamydia strain. We chose a murine lung infection model,
where the complexity of the in vivo environment—including
the impact of a variety of cytokines and cell-cell interactions—
could induce the expression of a diverse set of host genes. We
performed an unbiased study, where we explored the inducible
murine genes by screening the global gene expressions of the C.
muridarum infected murine lungs.
METHODS
Propagation of Chlamydia pneumoniae
and C. muridarum
Chlamydia pneumoniae (C. pneumoniae) CWL029 strain from
American Type Culture Collection (ATCC, Manassas, VA, USA)
was propagated in HEp-2 cells (ATCC), as described earlier
(Burián et al., 2003). C. muridarum strain Nigg (Nelson et al.,
2005) was grown in McCoy cells (ECACC, London, UK). After
partial purification and concentration the elementary bodies
(EBs) were aliquoted in sucrose-phosphate-glutamic acid buffer
(SPG) and stored at−80◦C until use (Caldwell et al., 1981).
Mice and Infection Conditions
Pathogen-free 6-week-old female BALB/c mice were obtained
from the Charles River Laboratories (Hungary), C57BL/6 mice
were obtained from BRC Animal House (Szeged, Hungary). The
mice were maintained under standard husbandry conditions at
the animal facility of the Department of Medical Microbiology
and Immunobiology, University of Szeged, and were provided
with food and water ad libitum. Before infection, the mice
were mildly sedated with an intraperitoneal injection of 200 µl
of sodium pentobarbital (7.5 mg/ml); they were then infected
intranasally with 4 × 105 IFU C. pneumoniae (BALB/c) or 1
× 103 IFU of C. muridarum (BALB/c and C57BL/6) in 20
µl SPG buffer. Control mice were treated with 20 µl SPG
buffer only. The mice were anesthetized and sacrificed 7 days
after infection. The lungs were removed and homogenized with
acid-purified sea sand (Sigma, St. Louis, MO, USA). Half of
each homogenized lung was processed for total RNA extraction,
and the other half was suspended in 1ml of SPG for the
detection of viable Chlamydia and to test the quantity of
kynurenine and tryptophan. The lungs of three mice from both
groups were fixed in 10% neutral buffered formalin solution
(Sigma) for histopathological evaluation. The experiments were
approved by the Animal Welfare Committee of the University
of Szeged and conform to the Directive 2010/63/EU of the
European Parliament.
Culturing of Chlamydia From Mouse Lungs
Homogenized lungs from individual mice were centrifuged
(10min, 400 g), serial dilutions of the supernatants were
inoculated onto McCoy cell monolayers and centrifuged (1 h,
800 g), and after a 48-h culture the cells were fixed with
acetone and stained with monoclonal anti-Chlamydia LPS
antibody (AbD Serotec, Oxford, UK) and FITC-labeled anti-
mouse IgG (Sigma). The number of the recoverable Chlamydia
inclusions was counted under a UV microscope and expressed
as IFU/lung.
In vivo IDO Inhibition by
1-Methyl-DL-Tryptophan
Seven days before infection with C. muridarum the drinking
water of 8 weeks old female BALB/c mice (n= 4) was changed to
that containing 2 mg/ml IDO inhibitor 1-methyl-DL-tryptophan
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(1-MT; Sigma), dissolved in 10 mmol/l NaOH supplemented
with Stevia sweetener. Control mice (n = 4) received the Stevia-
sweetened drinking water with 10 mmol/l NaOH without 1-
MT. The solution was delivered in autoclaved water bottles,
protected from light, and changed every other day. The infection
of mice and the estimation of recoverable viable C. muridarum
from the lungs at 7 days post infection were carried out as
described previously.
Total RNA Extraction and cDNA Synthesis
Total RNA was extracted from homogenized lung tissues of C.
muridarum infected BALB/c (n = 3) and C57BL/6 mice (n =
5), C. pneumoniae infected BALB/c mice and uninfected controls
with Tri Reagent according to the manufacturer’s protocol
(Sigma). Total RNA quantity (OD260) and purity (OD260/280)
were measured by a NanoDrop spectrophotometer (Thermo
Scientific, Waltham, MA, USA).
cDNA Library Preparation and Sequencing
cDNA library for RNA-Seq was generated from 1µg total BALB/c
lung RNA using TruSeq RNA Sample Preparation Kit (Illumina,
San Diego, CA, USA) according to the manufacturer’s protocol.
Single read 50 bp sequencing run was performed on Illumina
HiScan SQ instrument (Illumina). CASAVA software was used
for pass filtering and demultiplexing process. Sequenced reads
were aligned to Mus musculus mm10 genome version using
TopHat and Cuﬄinks algorithms and bam files were generated.
Statistical and Functional Analysis of
RNA-Sequencing Data
StrandNGS software (Agilent, Santa Clara, CA, USA) was used
for the statistical analysis of RNA-sequencing (RNA-Seq) data.
The aligned bam files were imported and DESeq algorithm
was used in the quantification step to generate normalized
gene expression data. Differentially expressed genes between
C. muridarum infected lung samples (n = 3) and controls
(n = 3) were determined using the Student’s t-test combined
with Benjamini-Hochberg FDR for multiple testing correction.
Statistical significance was defined as PBenjamini−Hochberg <
0.05. Library preparations, sequencing and data analysis
were performed by UD-GenoMed Kft. and the Genomic
Medicine and Bioinformatics Core Facility of University of
Debrecen, Debrecen, Hungary. Large scale functional analysis of
differentially expressed genes were performed by the Voronto
software (Santamaría and Pierre, 2012). The Voronto method
identifies the Gene Ontology terms and KEGG pathways that
contain significantly enriched differentially expressed genes.
Voronto software uses the so-called Voronoi tessellation to map
ontology terms or pathways into a map-like structure. The cells
of the map are the ontology terms, the closer terms being
located closer to each other. Terms with a common ancestor are
surrounded by a thicker line.
Quantitative PCR Validation of the IDO1
and IDO2 RNA-Seq Data
For quantitative PCR (qPCR) 1 µg of total RNA was reverse
transcribed using the Maxima Reverse Transcriptase according
to the manufacturer’s protocol with random hexamer priming
(Thermo Fisher Scientific Inc. Waltham, MA, USA). qPCR was
performed in a Bio-Rad CFX96 real-time system. The qPCR
was performed with the SsoFast EvaGreen qPCR Supermix
(Bio-Rad, Hercules, CA, USA) master mix and the murine
specific primer pairs IDO1: 5′-GCTTCTTCCTCGTCTCTCT
ATTG-3′, 5′-TCTCCAGACTGGTAGCTATGT-3′; IDO2: 5′-
CCTGGACTGCAGATTCCTAAAG-3′, 5′-CCAAGTTCCTGG
ATACCTCAAC-3′; beta-actin: 5′-TGGAATCCTGTGGCATCC
ATGAAAC-3′, 5′-TAAAACGCAGCTCAGTAACAGTCCG-3′.
To check the amplification specificity, the qPCR was followed by
a melting curve analysis. Threshold cycles (Ct) were calculated
for IDO1, IDO2 and beta-actin genes, and the normalized gene
expressions were calculated by the 1Ct method (CtIDO1-Ctactin
or CtIDO2-Ctactin). Statistical comparison of qPCR data was
performed by comparing the 1Ct values of uninfected and
infected lung samples (n = 3) by using the Student’s t-test as
described earlier (Yuan et al., 2006).
IDO1 and IDO2 Immunohistochemistry of
Chlamydia Infected and Uninfected Mouse
Lungs
IDO1 and IDO2 immunohistochemistry was performed on
the BALB/c lungs that were used in the gene expression
studies. Macroscopically inflamed lung sections and control
lungs were cut and fixed in 10% formalin (Sigma). Fixed
samples were cut into 4µm sections. Tissue sections
were first deparaffinized, followed by antigen retrieval and
inhibition of endogen peroxidases using the EnVision FLEX
Peroxidase-blocking reagent (Dako, Carpinteria, CA, USA).
IDO immunohistochemistry was performed with a goat
polyclonal anti-IDO1 antibody (Sigma) and a rabbit polyclonal
anti-IDO2 antibody (Bioss, Woburn, MA, USA) followed by
HRP-conjugated anti-goat rabbit (Dako) and anti-rabbit goat
secondary antibodies (Dako), respectively.
Detection of Tryptophan and Kynurenine
Concentrations in Lung Tissues
Infected and control BALB/c and C57BL/6 mouse lung tissues
were homogenized with sterile sand (Sigma), and dissolved
in 700 µl 1 × PBS. The samples were sonicated 2 × 1min,
vortexed and centrifuged at 500 g for 5min. Twenty microliters
of internal standard (3-nitro L-tyrosine (3NLT, Sigma), 2µM
final concentration in the sample) in 2.5 w/w% perchloric acid
was added to 480 µl supernatant and mixed with 500 µl
perchloric acid (2.5 w/w%). The samples were subsequently
centrifuged at 12,000 g for 10min at 4◦C, and the supernatants
were collected for measurement. The tryptophan and kynurenine
concentrations of the samples were quantified based on the
work of Hervé et al. (1996) with slight modifications (Veres
et al., 2015). In the high-performance liquid chromatography
(HPLC) analysis, the peak area responses were plotted against
the corresponding concentration, and the linear regression
computations were carried out using the least squares method
with the R software package (R Core Team, 2014).
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RESULTS
Chlamydia Infection and
Chlamydia-Induced Histopathology
In our animal model different doses of the two Chlamydia
strains were used (4 × 105 IFU of C. pneumoniae and 1 ×
103 IFU of C. muridarum), based on the results of our former
experiments (Burián et al., 2003; Kis et al., 2008) where the
lower dose of the murine pathogen C. muridarum induced
similar growth and histopathology than the human pathogen C.
pneumoniae. Indeed, recoverable IFUs from the C. muridarum
and C. pneumoniae infected BALB/c lungs were similar at 7 days
post infection (Figure 1A). Both infections induced a lymphoid
hyperplasia, with the interstitial accumulation of lymphoid,
plasmocytoid cells, and macrophages in the widened bronchus
walls. The histology picture was consistent with the formation
of inducible bronchus associated lymphatic tissue (iBALT). At
this time of the infection, the presence of neutrophils were
marginal, the major leukocyte populations were lymphocytes and
macrophages (Figures 1B,C). Control lung tissue showed thin
alveolar septa without the clear presence of inflammatory cells,
but a small number of pulmonarymacrophages could be detected
(Figure 1D).
Global Gene Expression Changes in the
C. muridarum Infected Mouse Lung
Tissues
To explore the global gene expression changes induced at the
tissue level by the murine Chlamydia strain we performed an
Illumina next generation RNA sequencing of BALB/c mouse
lung tissues infected with C. muridarum 7 days post infection.
RNA-seq analysis revealed that 755 murine genes had a higher
expression and 251 genes had a lower expression than the
uninfected control. The extent of up-regulation and the number
of up-regulated genes was higher (1.48–345 fold), than in the
case of the down-regulated genes (1.5–14.36 fold). The most
highly up-regulated gene was the CXCL11 (I-TAC), and several
cytokines/ chemokines were among the highly upregulated genes
including CXCL9 (MIG), CXCL10 (IP-10), CCL8 (MCP2), CCL2
(MCP1), IFNG, IL21, IL10, as well as already described defense
genes IRG1, IIGP and IDO1. The most highly down-regulated
gene was cDNA sequence BC023719 with a 14.36 fold of down-
regulation, and the functions of the most highly down-regulated
genes were diverse. The list of differentially expressed genes can
be found in the Supplementary Table 1.
Functional analysis of the differentially expressed genes using
the Voronto method revealed several KEGG pathways that are
related to Chlamydia-induced inflammation and antichlamydial
innate and adaptive defense responses (Figure 2A). Several up-
regulated genes rendered to cell-type specific KEGG pathways
such as T-cell, B-cell, NK-cell and hematopoietic cells-specific
pathways indicating the influx of these leukocytes into the
infected lung tissues. Indeed, increased expressions of various
cell-specific genes and CD markers were detected such as
T-cell markers CD3, CD4, CD5, CD6, CD7, CD226, B cells
markers CD5, CD7, dendritic cell marker CD4, NK-cell markers
CD4, CD7, natural killer cell lectin-like receptors (KLRA2,
KLRB1F, KLRK1, KLRI2, KLRC2, KLRD1) and macrophage-
specific genes CD4, MSR1, and MPEG1, indicating the influx
and/or local proliferation of these cells in the infected lung
tissue. Interestingly, when the up-regulated genes were compared
to the Mouse Gene Atlas gene expression database (Kuleshov
et al., 2016), the most significant overlap was detected with
the LPS treated macrophage gene expression (data not shown),
indicating the active involvement of activated macrophages in
the Chlamydia-induced gene expression changes. We detected
several highly upregulated chemokines, that could induce the
cellular influx, including the lymphocyte chemokines CCL2
(MCP1), CCL5 (RANTES), CCL8 (MCP2), CXCL9 (MIG),
CXCL10 (IP10), CXCL11 (I-TAC), the monocyte chemokines
CCL2, CCL4 (MIP1B), CCL7 (MCP3), CCL8 (MCP2), CXCL10
and the neutrophil granulocyte chemokine CXCL5 (ENA78).
Enhancing the effects of chemokines, various chemokine
receptors were also up-regulated including the MCP1 receptor
CCR2, the MCP1-MIP1-RANTES receptor CCR4, the MIP1B
receptor CCR5 and the MIG-IP10-I-TAC receptor CXCR3.
Gene Ontology molecular function analysis supported the
KEGG pathway analysis (Figure 2B). The fact that various “cell
cycle” pathway related genes were found to be up-regulated
indicates the accelerated division of activated cells including the
induction of BALT. The cellular activation is induced by ligand-
receptor interactions in both adaptive and innate immunity.
Indeed, among the largest functional groups identified were
“cytokine activity,” “transmembrane signaling” and “protein
kinase activity” containing prominently up-regulated and highly
up-regulated cytokines, cytokine receptors and downstream
signaling genes. Several adaptive immunity related genes, mainly
MHC-I antigen presentation related genes were up-regulated.
The pathogen recognition/proinflammation pathways such as
the toll-like receptor (TLR1, TLR6, TLR7, TLR12), cytosolic DNA
sensing, NOD-like, RIG-I-like pathways contained up-regulated
genes showing that the extra and intracellular forms of the
pathogen could be recognized and could induce an inflammatory
response. Among the cytokine signaling pathways, IFN-related
signaling pathways and IFN-induced gene expressions were
particularly noticeable, including up-regulated genes IFNG,
STAT1, STAT2, IRF7, IRF9, and IFN-induced genes such
as several histocompatibility complex genes, IFN-inducible
GTPases and tryptophan catabolism genes IDO1 and KYNU.
Antimicrobial Genes Induced by
C. muridarum Infection
A prominent identified Gene Ontology molecular functional
category was “GTP binding.” Most of the GTPases in this
category are involved in defense responses against intracellular
pathogens (Figure 2B). Essentially all four classes of murine
IFN-inducible GTPases were found to be up-regulated including
various guanylate-binding proteins (GBP2-9, GBP11), the
myxovirus resistance protein-1 (MX1), immunity-related
GTPases IRGM1 (LRG47), IRGM2 (GTPI), IRGA6 (IIGP),
IRGM3 (IGTP), IRGB6 (TGTP1-2), IRGB10 (Gm12250), and a
very large IFN-inducible GTPase GVIN1. It is worth to note,
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FIGURE 1 | Chlamydia infection and Chlamydia-induced histopathology in BALB/c mouse lung tissues. Recoverable IFUs from C. muridarum infected and C.
pneumoniae infected mouse lungs at 7 days post infection (A). Haematoxylin-eosin staining of C. muridarum infected (B), C. pneumoniae infected (C) and uninfected
(D) lung tissues. Bar is 50µm.
that three predicted genes with a sequence homology to IIGP
(Gm4841, Gm4951, F830016B08Rik) and three with a sequence
homology to TGTP (Gm12185, Gm5431, 9930111J21Rik1)
were found to be up-regulated or highly up-regulated in the
infected lungs (Figure 2B). Interestingly, Gm12185, Gm5431,
and 9930111J21Rik are localized on chromosome 11, close to
the region where potential defense genes against C. trachomatis
were found by QTL mapping (Bernstein-Hanley et al., 2006a,b).
Besides the IFN-inducible GTPases genes, other genes such as
CXCL9, iNOS, and IDO1 with known antichlamydial activity
against human and murine Chlamydia strains were highly
up-regulated (127 fold, 14 fold, and 24.7 fold, respectively).
Additional genes with known antimicrobial activity, but
unknown antichlamydial activity were found to be up-regulated
including CXCL11 (345 fold), IRG1 (252.7 fold), lipocalin-2 (11
fold), mucin-5 (8.7 fold) and solute carrier family 11 (5.5 fold).
qPCR Validation of IDO1 and IDO2
RNA-Seq Data
The fact that the IDO1 gene was highly upregulated (24.76
fold) in the infected lungs was an unexpected finding since the
IDO1 was found to be non-inducible by C. trachomatis or C.
muridarum infection in vitro in murine epithelial and other
cells (Nelson et al., 2005; Roshick et al., 2006; Burian et al.,
2010). IDO1 was detected as a significantly changed gene (P
= 0.037) between the C. muridarum infected and uninfected
samples, while the IDO2 was detected non-significant. However,
as Figures 3A,B shows, both IDO1 and IDO2 genes had more
sequence reads in the infected samples than the uninfected
ones. Yet, in the case of IDO2, the read numbers were not
high enough to be detected as a significantly changed gene.
We used qPCR as an independent method to validate RNA-
Seq data for IDO1 and IDO2. Also, in order to test whether
the IDO1-2 induction is unique to the murine Chlamydia strain,
we measured the IDO1-2 gene expressions in C. pneumoniae
infected lung samples. qPCR data supported the RNA-Seq
data in the case of C. muridarum infection with a 20.38 ±
11.3 fold and 38.2 ± 25.2 fold of upregulation of IDO1 and
IDO2, respectively. qPCR also showed a similar extent of up-
regulation 15.5 ± 14.1 fold and 88.9 ± 73.9 fold for IDO1
and IDO2, respectively in the C. pneumoniae infected lung
tissues (Figure 3C).
IDO1-2 Protein Expression in C. muridarum
and C. pneumoniae BALB/c Infected
Mouse Lung Tissues
To prove that the observed IDO1 and IDO2 mRNA changes
translated to protein expression changes, and to localize the
cell type(s) that express these proteins, we performed an
immunohistochemistry of C. muridarum and C. pneumoniae
infected lung sections and uninfected controls. Moderate IDO1-
2 positivity could be detected in the cytoplasm of bronchial
and occasionally alveolar epithelial cells and moderate/strong
positivity was detected frequently in macrophages in the C.
pneumoniae and C. muridarum infected mouse lung tissues
(Figure 4). C. pneumoniae and C. muridarum infections
lead to similar IDO1-2 positivity in these cells. The control,
uninfected lung tissues also contained IDO1-2 positive
bronchial epithelial cells, and a small number of IDO1-2
positive macrophages.
IDO 1-2 Activity in C. muridarum and C.
pneumoniae Infected BALB/c Mouse Lung
Tissues
To determine whether the expressed IDO1 and IDO2 proteins
were functional, we performed a HPLC analysis of the
infected and control lung tissues of mice included in the
gene expression and immunohistochemistry measurements. We
measured IDO1-2 activity by measuring the total tryptophan
level, and the level of the tryptophan degradation metabolite
kynurenine. The applied HPLC method could not detect
kynurenine in the uninfected lungs, while the C. muridarum
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FIGURE 2 | Functional analysis of the C. muridarum infection altered genes by the Voronto method. (A) Analysis of significantly enriched KEGG pathways containing
differentially expressed genes. (B) Gene Ontology analysis of significantly enriched molecular function terms containing differentially expressed genes. The differentially
expressed IFN-inducible GTPases are grouped based on their amino acid sequences shown separately with their fold of up-regulation. Chlamydia induced
inflammation, immunity and antichlamydial defense related Gene Ontology terms and KEGG pathways and the corresponding genes are shown separately. Cell colors
of the Voronto diagrams show the mean fold change (log2) of the differentially expressed genes related to the particular Voronto cells. Both for the Voronto cells and
the genes, the log2 fold changes are color coded according to the scales. Note that the colors of the up-regulated genes ranging from light blue to red, while the
down-regulated genes are dark blue.
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FIGURE 3 | IDO1 and IDO2 mRNA expression measurements by RNA-Seq and qPCR. Integrative Genomics Viewer (Thorvaldsdóttir et al., 2013) images showing the
coverage of IDO1 (A) and IDO2 (B) genes by sequencing reads in a representative C. muridarum infected and uninfected control samples. IDO1 and IDO2 gene
expression inductions measured by qPCR in C. muridarum and C. pneumoniae infected lung tissues (n = 3) (C). IDO1 and IDO2 gene expression fold changes in
each infected mice (n = 3) were calculated by comparing the average IDO1 and IDO2 expressions in the uninfected controls (n = 3). IDO1 and IDO2 gene expressions
were normalized by the beta-actin gene expressions. 1Ct values (CtIDO-Ctactin) of the infected and uninfected samples was compared by Student’s t-test. **P < 0.01
*P < 0.05.
FIGURE 4 | Detection of IDO1-2 protein expressions in Chlamydia infected and uninfected BALB/c mouse lungs. IDO1 protein and IDO2 protein expressions
detected by immunohistochemistry in C. muridarum infected, C. pneumoniae infected (7 days post infection) and uninfected control lung tissues. The IDO positive
epithelial cells are shown by gray triangles, the IDO positive macrophages are shown by black triangles. Bars: 50µm. The characteristic IDO stainings of epithelial cells
and macrophages are shown in brackets. Bars: 5µm.
and C. pneumoniae infected lungs contained 369.6 ± 199.8 nM
and 508.7 ± 176.6 nM. Since we could not control the cell
numbers in the infected and control tissues, we normalized the
samples by using the kynurenine/tryptophan ratios as described
previously (Veres et al., 2015). The kynurenine/tryptophan
ratios ranged from 0.12 to 0.22 in the C. muridarum infected
samples, 0.13–0.20 in the C. pneumoniae infected samples
and it was 0 in the control samples (Figure 5A). To assess
the impact of IDO activity on C. muridarum growth we
inhibited IDO1-2 by 1-MT treatment starting from seven
days before infection to seven days post infection (Figure 5B).
1-MT treatment lead to a moderate but significant, 1.98
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FIGURE 5 | Measurement of tryptophan degradation in the Chlamydia infected BALB/c lung tissues and the effect of IDO1-2 inhibition on C. muridarum growth. (A)
C. muridarum infected, C. pneumoniae infected and uninfected lung tissues (n = 3) were processed as described in the Materials and Methods for kynurenine and
tryptophan concentration measurements at 7 days post infection. Tryptophan degradation was described by measuring the kynurenine/tryptophan ratio.
Kynurenine/tryptophan ratios of each of the lungs analyzed are shown. Kynurenine concentrations of the uninfected samples were below the limit of detection. (B)
untreated (n = 4) and 1-MT treated (n = 4) BALB/c mice were infected with C. muridarum and the recoverable IFUs were measured at 7 days post infection.
Recoverable IFUs from each of the analyzed lungs are shown. Recoverable IFUs from untreated and 1-MT treated samples were compared by Student’s t-test.
*P < 0.05.
fold increase in C. muridarum recoverable IFU at 7 days
post infection.
IDO 1-2 mRNA Expression and Activity in
C. muridarum Infected C57BL/6 Mouse
Lung Tissues
To explore whether the Chlamydia-induced IDO1-2 activity
could be observed in another mouse strain, we performed
qPCR and HPLC analyses of C. muridarum infected and
control lung tissues of C57BL/6 mice. qPCR data showed a
significant increase of IDO1 mRNA level in the C. muridarum
infected lungs (fold of up-regulation range: 8.14–13.88), and
while the IDO2 mRNA up-regulation was not significant, an
up-regulation tendency could be observed (fold of up-regulation
range: 1.71–21.49) (Figure 6A). HPLC analysis of tryptophan
and kynurenine contents showed that uninfected C57BL/6
mice lungs contained a small amount of kynurenine (0.045–
0.075 kynurenine/tryptophan concentration ratios), and the
C. muridarum infection significantly increased the IDO
activity (0.185–0.773 kynurenine/tryptophan concentration
ratios) (Figure 6B).
DISCUSSION
RNA sequencing analysis of the C. muridarum infected lungs
revealed that the expression of a wide variety of host genes
were altered, and several up-regulated genes could contribute
in the Chlamydia-induced inflammation and antichlamydial
defense of the murine host. Genes related to both the innate
and adaptive immunity were found to be induced in the C.
muridarum infected lung tissue. The major functional “themes”
were related to cytokine/chemokine expression, chemotaxis,
signal transduction, antigen presentation, cell division and
innate antimicrobial defense. According to the cellular theory
of chlamydial pathogenesis, non-immune cells trigger the
inflammation by secreting proinflammatory cytokines and
chemokines (Stephens, 2003). While the cellular source of the
cytokines/chemokines cannot be identified by a tissue-level gene
expression analysis, in toto the strong gene expression imprint
of chemotaxis induction and cellular influx could be identified in
theC. muridarum infectedmouse lungs. The autocrine-paracrine
effects of the secreted cytokines and the cell-to-cell interactions
between resident and novel cells could result in a milieu that
induced a complex gene expression including the induction of
certain antichlamydial genes.
Several members of the IFN-inducible GTPase family were
found to be highly induced. Although we did not measure the
gene expression changes induced by the C. pneumoniae, previous
studies showed that both the murine and human Chlamydia
strains were able to induce IFN-inducible GTPases (Nelson et al.,
2005; Burian et al., 2010). GTPases IRGM1 (LRG47), IRGM3
(IGTP), IRGA6 (IIGP), and IRGB10were found to be upregulated
or highly-upregulated, and have been shown to be involved in
the clearance of the human C. trachomatis strain (Nelson et al.,
2005; Bernstein-Hanley et al., 2006b; Coers et al., 2008), but
likely not effective against the murine Chlamydia (Nelson et al.,
2005; Coers et al., 2008). Novel GTPase genes were also found
to be highly up-regulated after C. muridarum infection, and
could be involved in the antichlamydial defense. Three of these
genes (Gm12185, Gm5431, 9930111J21Rik1) show a sequence
similarity to IRGB10, a known murine defense gene against C.
trachomatis (Bernstein-Hanley et al., 2006b). Interestingly, Coers
et al. showed that C. muridarum was capable of evading the
antichlamydial effect of IRGB10 (Coers et al., 2008). Altogether,
the differential sensitivity to the IFN-inducible GTPases could
explain the fact that despite using 400 fold more C. pneumoniae
IFU than C. muridarum,we recovered comparable IFUs from the
infected lungs. The other known antichlamydial gene iNOS was
also up-regulated (14 fold). iNOS induction has been shown to
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FIGURE 6 | qPCR measurement of IDO1 and IDO2 gene expressions in the C. muridarum infected C57BL/6 lung tissues (A). IDO1 and IDO2 gene expression fold
changes in each infected mice (n = 5) were calculated by comparing the average IDO1 and IDO2 expressions in the uninfected controls (n = 5). IDO1 and IDO2 gene
expressions were normalized by the beta-actin gene expressions. 1Ct values (CtIDO-Ctactin) of the infected and uninfected samples was compared by Student’s
t-test. **P < 0.01. N/A: IDO2 mRNA expression could not be detected. (B) Measurement of tryptophan degradation in the C. muridarum infected C57BL/6 lung
tissues. C. muridarum infected and uninfected lung tissues (n = 5) were processed as described previously at 7 days post infection. Kynurenine/tryptophan
concentration ratios of each of the lungs analyzed are shown. Kynurenine/tryptophan concentration ratios of C. muridarum infected and uninfected samples were
compared by Student’s t-test. **P < 0.01.
be an important mechanism in the later phase elimination of C.
muridarum infection from themouse genital tract (Johnson et al.,
2012) and also in RAW 264.7 murine macrophages (Rajaram
and Nelson, 2015). IRG1, another IFN-inducible gene (Tallam
et al., 2016) (Naujoks et al., 2016) was found to be highly
up-regulated (252.7 fold) after C. muridarum infection. IRG1
was shown to be expressed in macrophages (Hall et al., 2013;
Naujoks et al., 2016), associated with Legionella pneumophila
vacuoles in macrophages and possessed antimicrobial activity
by increasing reactive oxygen species production (Hall et al.,
2013) and by the direct bactericidal effect of itaconic acid
production (Naujoks et al., 2016). A CXC chemokine, MIG was
also highly up-regulated (127 fold) after C. muridarum infection.
We showed previously that MIG had a concentration-dependent
direct toxicity to the elementary bodies of C. muridarum,
C. trachomatis (Burian et al., 2010) and C. pneumoniae
(Balogh et al., 2011).
RNA sequencing and qPCR revealed that the IDO1 and
IDO2 genes were also highly induced in the infected lungs. To
identify the source of IDO activity, we performed IDO1-2 IHC in
infected and control lung tissues. We found that lung bronchial
epithelial cells had a moderate level of IDO1-2 positivity both
in the control and infected tissues, indicating a lower-level,
steady-state expression. A higher level of IDO1-2 positivity was
detected in leukocytes, prominently in macrophages, in both
the uninfected and infected tissues, but the number of positive
cells was higher in the Chlamydia-infected tissues. The higher
number of IDO1-2 positive macrophages might be a result of
in situ IDO1-2 induction and/or the influx of already IDO1-2
positive monocytes into the inflamed tissue. It is also possible that
the IDO1-2 positive macrophages were activated locally resulting
in a higher IDO1-2 activity. Previous in vivo studies showed a
tissue level IDO induction in various murine tissues infected by
Escherichia coli (Loughman and Hunstad, 2012), Plasmodium
berghei (Sanni et al., 1998), and Toxoplasma gondii (Fujigaki
et al., 2002). Interestingly, C. pneumoniae induced lung IDO1
expression was also shown in RAG−/− mice, but not in the wild
type C57BL/6 controls (Rottenberg et al., 2000). Cellular level
IDO induction in vivowas detected inmurine intestinal epithelial
cells after Eimeria falciformis infection (Schmid et al., 2012),
in lung epithelial cells after influenza A virus infection (Huang
et al., 2013) and in lung epithelial cells, endothelial cells and
macrophages/dendritic cells after Mycobacterium tuberculosis
infection (Desvignes and Ernst, 2009). Knockout studies showed
that—similarly to humans—one of the major inducers of IDO
expression is IFNG and IFNA/B in murine tissues in vivo
(Loughman and Hunstad, 2012; Huang et al., 2013). According
to our gene expression data one of the prominent networks
induced by C. muridarum infection was the IFN signaling
pathway, therefore the IFN impact of IDO1-2 gene induction
was clearly present in the Chlamydia-infected tissues. HPLC
detection of the tryptophan degradation product kynurenine in
BALB/c lungs demonstrated that i, in the uninfected murine
lung tissues IDO activity was not detectable, hence the low level
IDO1-2 protein positivity detected in uninfected epithelial cells
and macrophages did not yield significant tryptophan catabolism
ii, IDO1-2 enzymes were induced and functionally active in
both the murine and human Chlamydia infected lung tissues.
A quantitative IHC was not performed, but the observation of
similar level of IDO1-2 IHC positivity in epithelial cells before
and after infection indicates that the IDO1-2 were not induced
and IDO1-2 activity might not be involved in the elimination
of Chlamydia from the murine lung epithelial cells. Further
quantitative studies needed to clarify the exact role of murine
epithelial IDO expression. The fact that the C57BL/6 mouse
lungs also showed Chlamydia infection induced IDO activity
supports that the observed IDO induction is not a mouse strain-
specific response.
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The role of murine IDO in the clearance of Chlamydia
in vivo is not well-defined. IDO1 knockout mice cleared C.
muridarum from the urogenital tract with similar—but not
identical—kinetics to the wild types (Nelson et al., 2005), but
it should be noted that IDO2 gene was intact in these animals
(Mellor et al., 2003; Blumenthal et al., 2012). To clarify the
antimicrobial role of IDO1-2 activity we treated BALB/c mice
with 1-MT, a previously described inhibitor of IDO1 (Cady
and Sono, 1991) and IDO2 (Metz et al., 2007). IDO inhibition
showed that there was a moderate but significant, ∼2 fold
increase in C. muridarum recoverable IFU in 1-MT treated
mice indicating that IDO activity influenced the C. muridarum
replication in vivo.
Both the C. muridarum and C. pneumoniae infections
clearly lead to the presence of IDO1-2 positive macrophages,
and this leukocyte influx/activation was a major factor in
the observed increase in IDO1-2 activity. Monocytes have
been implicated in the spread of C. pneumoniae from
the primary site of infections (Beagley et al., 2009), but
human monocytes were able to suppress C. trachomatis
growth via IDO-dependent (Carlin and Weller, 1995)
and IDO-independent mechanisms (Koehler et al., 1997;
Nettelnbreker et al., 1998; Marangoni et al., 2014). Whether
the IDO activity of murine macrophages contributes to the
control of C. muridarum and C. trachomatis growth, needs
further investigation.
There are limitations of our study that need further
investigations. We could not detect IDO 1-2 inducibility in
epithelial cells, but the applied IHC was not a quantitative
method. Since epithelial cells are the sites of chlamydial
replication, the isolation of lung epithelial cells and the
measurement of their steady state and infection-induced IDO
activity are critical points and a goal we are currently
pursuing. The other obvious targets to assess IDO activity
are the isolated epithelial cells of the uninfected and infected
murine urogenital tract. The role of IDO2 is not defined.
The lung IDO2 mRNA was clearly induced by Chlamydia
infection, but its RNA-seq read numbers were significantly
lower than IDO1 reads. In order to assess the potential role
of IDO2, the IDO2 protein concentrations in isolated lung
epithelial cells and macrophages has to be measured and
compared to IDO1. Also, chemical inhibition of IDO showed a
significant, albeit limited phenotypic effect. This could be due
to the limited defensive role of IDO 1-2 or the incomplete
inhibition of the enzymes. Further studies with optimized
IDO inhibition protocol and more time points post infection
are needed.
Chlamydia can avoid intracellular defense responses
by using metabolic shunt (Aiyar et al., 2014), inactivating
cellular effector proteins such as IFN-inducible GTPases
(Nelson et al., 2005; Coers et al., 2008), or avoiding the induction
of the intracellular effectors (Marangoni et al., 2014). Our in
vivo study showed that –at the tissue level- various antibacterial
mechanisms are switched on and IDO1-2 could be part of this
effector repertoire.
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